Source: Annual Congress 2003 - Asthma: control, quality of life, exhaled breath, rhinitis and cough
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Plavsic, B. S. Gvozdenovic, N. Tasic, D. Tasic (Belgrade, Yugoslavia). Are a degree of asthma therapy related to asthma control impairment?. Eur Respir J 2003; 22: Suppl. 45, 2332

Member's Comments

No comment yet.

Related content which might interest you: Is a degree of asthma therapy related to pulmonary function impairment? Source: Eur Respir J 2001; 18: Suppl. 33, 41s Year: 2001 Can control of severe asthma be achieved? Source: Eur Respir J 2005; 26: Suppl. 49, 51s Year: 2005 Difficult-to-treat asthma: how serious is the problem and what are the issues? Source: Eur Respir Mon 2011; 51: 1-15 Year: 2011 How much is too much? The treatment of mild asthma Source: Eur Respir J 2007; 30: 403-406 Year: 2007 Only severe asthma? Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020 Year: 2021 Omalizumab improves asthma control in patients receiving high-dose ICS and multiple other controller therapies and who have continuing impairment of lung function and asthma symptoms Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Is quality of life impairment in asthma comparable to chronic urticaria? Source: Eur Respir J 2007; 30: Suppl. 51, 627s Year: 2007 Are there sub groups of children with asthma where FeNO guided treatment is associated with reduced risk for asthma attacks? Source: International Congress 2017 – Diagnostic tools in paediatric asthma Year: 2017 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 How does obesity correlate with severe asthma? Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 Dupilumab improves asthma control and quality of life in children with uncontrolled persistent asthma Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Is omalizumab response influenced by passive smoking in severe asthma? Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Refining asthma treatment for mild asthma Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005 Effect of BMI on asthma control, asthma severity and quality of life in adult patients with asthma Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control Year: 2011 The occupational contribution to severe exacerbation of current asthma Source: Annual Congress 2009 - Environmental factors, susceptibility, asthma and COPD Year: 2009 Predictors of response to therapy with omalizumab in patients with severe allergic asthma–a real life study Source: International Congress 2017 – Monitoring asthma control Year: 2017